Medi Home Health And Hospice - Chesapeake 1112 B Eden Way North, Suite 200, Chesapeake, VA, 23320 | |
(757) 420-7192 |
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
Name | Medi Home Health And Hospice - Chesapeake |
---|---|
Location | 1112 B Eden Way North, Suite 200, Chesapeake, Virginia |
Hospice ID | 491576 |
Category | Part of a Home Health Agency |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 194 |
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
NPI Number | 1497700454 |
Organization Name | Medi Home Health Agency, Inc. |
Address | 530 Independence Pkwy Chesapeake, Virginia, 23320 |
Phone Number | (757)420-7192 |
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.2 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.2 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 97.6 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 50.3 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.2 | 97.3 |
Patients who got timely treatment for shortness of breath | 99.4 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 99.4 | 93.3 |
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
Home Health Aides | 20 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 12 |
Medical Social Workers | 6 |
Physicians | 3 |
Registered Nurses | 29 |
Other Personnel | 3 |
Total Employees | 74 |
---|
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
Others | 13 |
Total Volunteers | 13 |
---|
News Archive
LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given "fast track" status by the FDA.
Breast cancer patients whose treatment includes radiation therapy are at higher risk of complications after implant-based breast reconstruction, reports a study in the April issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
On September 11, firefighters, police officers and ambulance workers faced a terrifying rescue effort in the World Trade Center complex. They battled to save people from the collapsing Twin Towers, searched for survivors, tackled fires and evacuated as many people as they could in an area which contained an estimated 17,000 people.
The first U.S. population prevalence study of mutations in the gene that causes fragile X syndrome, the most common inherited form of intellectual disability, suggests the mutation in the gene - and its associated health risks - may be more common than previously believed.
› Verified 3 days ago
Sentara Home Care Services - Chesapeake Location: 535 Independence Parkway, Suite 200, Chesapeake, Virginia, 23320 Phone: (757) 420-7192 |
Comfortcare Home Health And Hospice Location: 667 Kingsborough Square Suite 201, Chesapeake, Virginia, 23320 Phone: (757) 420-7192 |
Medi Home Health And Hospice - Chesapeake Location: 1112 B Eden Way North, Suite 200, Chesapeake, Virginia, 23320 Phone: (757) 420-7192 |
Compassionate Care Hospice Location: 920 Ventures Way, Suites 5, Chesapeake, Virginia, 23320 Phone: (757) 420-7192 |